For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
The federal government and stakeholders interested in device innovation and evaluation should support the creation of a comprehensive partnership on medical devices to monitor the products' performance after they become commercially available, a Food and Drug Administration-initiated and independent national group of experts is recommending in a report. The recommendations call for a master network of data in each clinical area where devices are used.
